Literature DB >> 25956342

The effects of surgery-induced immunosuppression and angiogenesis on tumour growth.

Tsuyoshi Kadosawa1, Ai Watabe2.   

Abstract

Surgical removal of primary tumours can help in the treatment of cancer but carries the risk of triggering the proliferation of dormant micrometastases. Many experimental and clinical studies have demonstrated that anti-angiogenic mechanisms and immune surveillance are essential to inhibit metastatic tumour cells from growing. As surgical stress often induces a reduction in anti-angiogenic factors in parallel with increases in angiogenic factors and suppression of immune surveillance during the post-operative period, new strategies for peri-operative immunostimulation and chemotherapy are required. This review summarises the factors and proposed mechanisms underlying the effects of surgery on immunosuppression and angiogenesis.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Dormancy; Immunosuppression; Micrometastases; Oncology; Surgical stress

Mesh:

Year:  2015        PMID: 25956342     DOI: 10.1016/j.tvjl.2015.04.009

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  4 in total

1.  Optimal adjuvant chemotherapy completion time for stage III colon cancer: a cohort study.

Authors:  Jing-Qing Ren; Han-Shuo Zhang; Li-Hua Zhang; Qi-Guang Zhong; Fan Wu; Bai-Lin Wang; Shao-Jie Liu
Journal:  J Gastrointest Oncol       Date:  2021-08

Review 2.  Surgical trauma-induced immunosuppression in cancer: Recent advances and the potential therapies.

Authors:  Fan Tang; Yan Tie; Chongqi Tu; Xiawei Wei
Journal:  Clin Transl Med       Date:  2020-01

Review 3.  Outcomes of enhanced recovery after surgery in lung cancer: A systematic review and meta-analysis.

Authors:  Wenhui Zhang; Yuting Zhang; Yi Qin; Jiahai Shi
Journal:  Asia Pac J Oncol Nurs       Date:  2022-06-30

4.  Pretreatment lymphopenia is an easily detectable predictive and prognostic marker in patients with metastatic esophagus squamous cell carcinoma receiving first-line chemotherapy.

Authors:  Furong Kou; Zhihao Lu; Jian Li; Xiaotian Zhang; Ming Lu; Jun Zhou; Xicheng Wang; Jifang Gong; Jing Gao; Jie Li; Yan Li; Lin Shen
Journal:  Cancer Med       Date:  2016-01-26       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.